178
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Comparing the use of cobalt chromium stents to stainless steel stents in primary percutaneous coronary intervention for acute myocardial infarction: A prospective registry

, , , , , , & show all
Pages 219-222 | Received 21 Sep 2011, Accepted 16 Oct 2011, Published online: 05 Dec 2011

References

  • Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, . Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–23.
  • Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, . A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221–31.
  • Violini R, Musto C, De FF, Nazzaro MS, Cifarelli A, Petitti T, . Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial. J Am Coll Cardiol. 2010;55:810–4.
  • Di LE, Sauro R, Varricchio A, Carbone G, Cortese G, Capasso M, . Long-term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: Results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in primary angioplasty (PASEO) randomized trial. Circulation 2009;120:964–72.
  • Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med. 2009;360:1946–59.
  • Bocksch W, Pomar F, Dziarmaga M, Tresukosol D, Ismail O, Janek B, . Clinical safety and efficacy of a novel thin-strut cobalt-chromium coronary stent system: Results of the real world coroflex blue registry. Catheter Cardiovasc Interv 2010;75:78–85.
  • Kereiakes DJ, Cox DA, Hermiller JB, Midei MG, Bachinsky WB, Nukta ED, . Usefulness of a cobalt chromium coronary stent alloy. Am J Cardiol. 2003;92:463–6.
  • Kastrati A, Hall D, Schomig A long-term outcome after coronary stenting. Curr Control Trials Cardiovasc Med. 2000;1:48–54.
  • Schofer J, Schluter M. Are drug-eluting stents a panacea for patients with coronary heart disease? Lancet 2004;364:558–9.
  • Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Munzel T, . Randomized, double-blind, multicenter study of the endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation 2006;114:798–806.
  • Serruys PW, Ong AT, Piek JJ, Neumann FJ, van der Giessen WJ, Wiemer M, . A randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. EuroIntervention 2005;1:58–65.
  • Visconti G, Focaccio A, Tavano D, Airoldi F, Briguori C. The CID Chrono cobalt-chromium alloy carbofilm-coated coronary stent system. Int J Cardiol. 2010;149(2):199–204.
  • Sketch MH, Jr, Ball M, Rutherford B, Popma JJ, Russell C, Kereiakes DJ. Evaluation of the medtronic (driver) cobalt-chromium alloy coronary stent system. Am J Cardiol 2005;95:8–12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.